Bronchiolitis - inpatient outcomes | ||||||||
---|---|---|---|---|---|---|---|---|
Clinical score | Length of stay | |||||||
Time point for clinical score assessment | Patients (studies) | Effect estimate SMD (95 % CI) | I2 (%) | Quality of evidence | Patients (studies) | Effect estimate MD (95 % CI) | I2 (%) | Quality of evidence |
Glucocorticoids vs. placebo | ||||||||
At 1–3 days | 113 (4) | −0.74 (−1.48,1.01) | 70 | Low | 633 (8) | −0.18 (−0.39,0.04) | 16 | High |
Bronchodilator vs. placebo | ||||||||
No data | 349 (6) | 0.06 (−0.27,0.39) | 0 | Moderate | ||||
Epinephrine vs. placebo | ||||||||
At 60 min | 232 (2) | −0.04 (−0.49, 0.40) | 46 | Moderate | 292 (2) | −0.35 (−0.87,0.17) | 0 | Moderate |
Epinephrine vs. bronchodilator | ||||||||
At 60 min | 248 (4) | −0.79 (−1.45,-0.13) a | 79 | Low | 261 (4) | −0.28 (−0.46,-0.09) a | 0 | Moderate |
At 120 min | 140 (1) | −0.52 (−0.68,-0.18) a | NA | Low | ||||
3 % hypertonic saline vs. 0.9 % saline | ||||||||
At 1–3 days | 183 (3) | −0.84 (−1.39,-0.30) | 66 | Low | 282 (4) | −1.16 (−1.55,-0.77) a | 0 | Moderate |
At 3–10 days | 156 (3) | −1.08 (−2.47,0.31) | 93 | Moderate | ||||
Chest physiotherapy vs. standard care or other drainage/breathing technique | ||||||||
At 1–3 days | 87 (1) | −0.55 (−0.98,-0.12) a | NA | Low | 172 (3) | 0.07 (−0.58,0.73) | 0 | Low |
At 3–10 days | 91 (2) | −0.14 (−0.81,0.53) | 59 | Low |